Diagnostic evaluation of patients with metastatic bone disease

Metastatic carcinoma to bone of uncertain primary origin is a common clinical problem that presents to practicing orthopaedic surgeons. The authors present a simple and effective staging system to identify primary malignancies. The role of clinical history, physical examination, laboratory studies, and limited radiographic studies are critical to the success of this diagnostic strategy. Needle or open biopsy frequently is needed yet is usually more effective as a confirmatory study for carcinoma or to rule out primary bone sarcomas. Patients who present with a displaced pathologic fracture require urgent diagnostic and treatment plans that do not compromise future treatment options particularly if the lesion is a primary sarcoma, in which durable skeletal reconstruction is possible.

[1]  D. Panicek,et al.  Biopsy of suspicious bone lesions in patients with a single known malignancy: prevalence of a second malignancy. , 2013, AJR. American journal of roentgenology.

[2]  A. Ahmed,et al.  Primary bone metastasis as initial presentation of endometrial cancer (stage IVb) , 2013, Archives of Gynecology and Obstetrics.

[3]  K. Hemminki,et al.  Site‐specific survival rates for cancer of unknown primary according to location of metastases , 2013, International journal of cancer.

[4]  Ha Yeon Lee,et al.  Clinical presentation of carcinoma of unknown primary: 14 years of experience , 2011, Tumor Biology.

[5]  K. Chorneyko,et al.  The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. , 2005, Annals of diagnostic pathology.

[6]  K. Oien,et al.  Hunting the primary: novel strategies for defining the origin of tumours , 2005, The Journal of pathology.

[7]  C. Nanni,et al.  Role of 18F-FDG PET–CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Masaru Suzuki,et al.  Immunohistochemistry for the differentiation of peritoneal disseminated carcinoma of unknown origin. , 2004, Internal medicine.

[9]  A. Folpe,et al.  CDX-2, a New Marker for Adenocarcinoma of Gastrointestinal Origin , 2004, Advances in anatomic pathology.

[10]  A. Hartmann,et al.  Cancer of unknown primary: clinicopathologic correlations , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  F. Frassica,et al.  Presentation and staging of metastatic bone disease. , 2003, Clinical orthopaedics and related research.

[12]  B. Rougraff Evaluation of the patient with carcinoma of unknown origin metastatic to bone. , 2003, Clinical orthopaedics and related research.

[13]  J. Hainsworth,et al.  Diagnostic and therapeutic management of cancer of an unknown primary. , 2003, European journal of cancer.

[14]  Tian-Li Wang,et al.  Identifying tumor origin using a gene expression-based classification map. , 2003, Cancer research.

[15]  A. Papadopoulou,et al.  Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management. , 2003, Neoplasia.

[16]  O. Guérin,et al.  Cancers d'origine indéterminée : à propos de 311 cas , 2001 .

[17]  E. Gamelin,et al.  [Cancers of unknown origin: 311 cases]. , 2001, Bulletin du cancer.

[18]  L. Skoog,et al.  Cytological diagnosis of skeletal lesions. Fine-needle aspiration biopsy in 110 tumours. , 2000, The Journal of bone and joint surgery. British volume.

[19]  J. Maillefert,et al.  Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin , 2000, Cancer.

[20]  H. Iwata,et al.  Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin , 1999, Cancer.

[21]  S. Pinder,et al.  Is mammography of value in women with disseminated cancer of unknown origin? , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).